VCEL

NASD Vericel Corporation

Nov 7, 2026 · 8:30 AM ET EOD Market Closed

$54.62 ↑ +0.00 (+0.00%) Trading Up from the previous close of $54.62, $0.02 below the day’s high of $54.64

YTD change: +51.68%
vs 20-day SMA: +30.17%
vs 200-day SMA: +40.79%

Price ranges

Previous day

$50.76 $54.64

open $51.78 close $54.62

+$2.84 (+5.48%)

Today

$50.76 $54.64

$54.62

Past week

$39.44 $55.60

from $42.91 now $54.62

+$11.71 (+27.29%)

Past month

$39.00 $55.60

from $40.05 now $54.62

+$14.57 (+36.38%)

This year

$28.95 $55.60

from $36.01 now $54.62

+$18.61 (+51.68%)

Price & Performance

+19.49 (+55.48%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 20.8% away from all-time highs of $68.94
VCEL is up 52% since the beginning of the year
VCEL is up 41% over the past 12 months
VCEL is up 36% over the past 1 month
10% of all VCEL investors are betting against VCEL

VCEL reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +40.3%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.27

Earnings momentum +93.1% Quarterly EPS growth

Quarterly change +93.1%

Valuation

P/E ratio 96.77

Enterprise value $2.6B

Beta 1.05

Balance sheet & scale

Income$24.2K

Revenue$306.3M

Cash$162.5M

Debt$94.6K

Income / Debt 0.26×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $2.8B

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies for use in the treatment of patients with diseases. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Competitor comparison

Ticker	Company	Price	Change
CMXHF	CSL Limited	$139.16	+3.08%
ARGX	argenx SE Sponsored ADR	$927.21	+3.63%
ONC	BeOne Medicines Ltd. Sponsored ADR	$406.96	+5.09%
WXXWY	WuXi Biologics (Cayman) Inc. Unsponsored ADR	$12.38	+1.06%
INCY	Incyte Corporation	$119.65	+1.39%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.